Insulin Glargine Injection

  • Favorite
Newlystar (Ningbo) Medtech Co., Ltd.

Business Type:Trader

Country/Region:China

Ddu Verified

HOT Rank

8/10

Product Information

  • Dosage Form:Injection
  • Route of Administration:Subcutaneous Injection
  • Shelf Life:3 years
  • Storage:Sealed

Description

Product : Insulin Glargine Injection

Specification : 300 Units/3 mL, 1000 Units/10 mL

Standard : BP, USP

Packing:10*10amps/box


Description:

Insulin glargine [rDNA origin] injection is a sterile solution of insulin glargine for use as a subcutaneous injection. Insulin glargine is a recombinant human insulin analog that is a long-acting (up to 24-hour duration of action), parenteral blood-glucose-lowering agent. Insulin glargine injection is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli (K12) as the production organism. Insulin glargine differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine and two arginines are added to the C-terminus of the B-chain. Chemically, insulin glargine is 21A-Gly-30Ba-L-Arg-30Bb-L-Arg-human insulin and has the empirical formula C267H404N72O78S6 and a molecular weight of 6063.

Insulin glargine injection consists of insulin glargine dissolved in a clear aqueous fluid. Each milliliter of Insulin glargine injection (insulin glargine injection) contains 100 Units (3.6378 mg) insulin glargine.


Indications and Usage :

Insulin glargine injection is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Important Limitations of Use:

Insulin glargine injection is not recommended for the treatment of diabetic ketoacidosis. Intravenous short-acting insulin is the preferred treatment for this condition.


You Might Also Like
Change a group
Inquiry Cart(0)